Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Astrid Weiß(Justus-Liebig-Universität Gießen), Ralph T. Schermuly(Justus-Liebig-Universität Gießen)
Cited by 96
Related Papers
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|778
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
|American Journal of Respiratory Cell and Molecular Biology|2017|119
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
|PLoS ONE|2012|113
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
|Communications Biology|2021|15